Company research / CFOR

CapForce Inc. (CFOR)

CIK 0001293818 · OTC · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, CapForce Inc. reported revenue of $30.20M. Revenue grew 481.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $76.20M.

Key ratios (year ended 2025-12-31)

79.6%
Operating margin
78.2%
Net margin
74.1%
Return on year-end equity
481.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-19

Headquarters locality: Gaithersburg / Gaithersburg · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-30; 1-for-10, first reflected in a filing dated 2024-06-03. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$76.20M$30.20M$5.20M$3.42M$2.61M$4.31M$4.21M$3.50M$2.95M$3.21M$4.03M
Cost of Revenuen/an/an/a$3.08M$3.32M$2.30Mn/an/an/an/an/a
Gross Profit (computed)n/an/an/a$334.2K-$712.3K$2.01Mn/an/an/an/an/a
R&D Expensen/a$6.6K$48.8K$4.73M$8.17M$10.91M$9.96M$5.12M$5.68M$6.88M$8.61M
Operating Income$64.63M$24.03M$324.7K-$30.75M-$34.57M-$23.27M-$22.72M-$12.27M-$13.18M-$15.27M-$19.01M
Depreciation & Amortization$200.5K$191.5K$174.8K$1.32M$1.64M$2.71M$2.33M$921.4K$730.9K$669.1K$656.0K
EBITDA$64.83M$24.22M$499.5K-$29.43M-$32.92M-$20.56M-$20.38M-$11.35M-$12.45M-$14.60M-$18.35M
Net Income$62.28M$23.62M$11.99M-$32.67M-$37.28M-$34.81M-$26.21M-$12.45M-$13.37M-$15.42M-$19.17M
EPS (Diluted)n/a$2.32$2.30-$41.47-$152.70-$22.89n/an/an/an/an/a
Total Assets$87.68M$38.06M$9.86M$1.88M$25.81M$71.67M$49.75M$10.42M$8.95M$6.62M$8.98M
Total Liabilities$13.40M$6.20M$2.48M$13.44M$18.24M$30.45M$28.56M$6.13M$5.64M$5.22M$5.82M
Long-Term Debtn/an/an/an/a$4.85M$7.18M$19.38M$329.5Kn/an/an/a
Shareholders' Equity$74.28M$31.86M$7.38M-$11.56M$7.58M$41.22M$21.19M$4.29M$3.31M$1.40M$3.17M
Cash & Equivalents$143.8K$531.3K$1.31M$1.15M$7.44M$36.08M$13.36M$2.71M$4.57M$1.85M$4.12M
Operating Cash Flow-$1.52M-$1.18M-$4.87M-$14.32M-$20.45M-$21.48M-$23.40M-$11.51M-$11.07M-$14.30M-$17.25M
Capital Expendituresn/a$50.0Kn/a$800.4K$590.8K$1.98M$130.4K$31.8K$147.8K$276.9K$123.5K
Free Cash Flown/a-$1.23Mn/a-$15.12M-$21.04M-$23.46M-$23.53M-$11.54M-$11.22M-$14.58M-$17.37M
Shares Outstanding12.40M10.15M10.07M1.28M290.0K2.32M25.09M5.58M432.3K2.27M1.01M
Weighted Average Diluted Sharesn/a10.13M5.22M787.8K244.2K1.83Mn/an/an/an/an/a
EPS (Basic)n/a$2.33$2.44-$41.47-$152.70-$22.89n/an/an/an/an/a